Emerging treatment options for patients with p53-pathway-deficient CLL.

17p deletion CLL TP53 mutation ibrutinib idelalisib venetoclax

Journal

Therapeutic advances in hematology
ISSN: 2040-6207
Titre abrégé: Ther Adv Hematol
Pays: England
ID NLM: 101549589

Informations de publication

Date de publication:
2019
Historique:
received: 02 08 2019
accepted: 06 11 2019
entrez: 17 12 2019
pubmed: 17 12 2019
medline: 17 12 2019
Statut: epublish

Résumé

Over the past 40 years, p53 has been the most widely studied protein in cancer biology. Originally thought to be an oncogene due to its stabilization in many cancers, it is now considered to be one of the most critical tumor suppressors in a cell's ability to combat neoplastic transformation. Due to its critical roles in apoptosis, cell-cycle arrest, and senescence,

Identifiants

pubmed: 31839919
doi: 10.1177/2040620719891356
pii: 10.1177_2040620719891356
pmc: PMC6896129
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

2040620719891356

Subventions

Organisme : NCI NIH HHS
ID : R01 CA207204
Pays : United States

Informations de copyright

© The Author(s), 2019.

Déclaration de conflit d'intérêts

Conflict of interest statement: The author(s) declare that there is no conflict of interest.

Références

N Engl J Med. 2019 May 30;380(22):2095-2103
pubmed: 31141631
Science. 1990 Nov 30;250(4985):1233-8
pubmed: 1978757
Blood. 2017 Jun 29;129(26):3419-3427
pubmed: 28424162
J Am Chem Soc. 2014 Apr 23;136(16):5860-3
pubmed: 24697838
Genes Dev. 2001 May 1;15(9):1067-77
pubmed: 11331603
Nature. 1992 Mar 19;356(6366):215-21
pubmed: 1552940
Leuk Lymphoma. 2015;56(10):2779-86
pubmed: 25726955
Blood. 2013 Aug 15;122(7):1266-70
pubmed: 23821658
J Clin Oncol. 2012 Sep 10;30(26):3209-16
pubmed: 22869884
Lancet. 2010 Oct 2;376(9747):1164-74
pubmed: 20888994
N Engl J Med. 2016 Jan 28;374(4):311-22
pubmed: 26639348
Cancer Res. 2010 Sep 15;70(18):7148-54
pubmed: 20736370
N Engl J Med. 2018 Dec 27;379(26):2517-2528
pubmed: 30501481
Blood. 2011 Mar 17;117(11):3016-24
pubmed: 21245487
N Engl J Med. 2000 Dec 14;343(24):1750-7
pubmed: 11114313
Blood. 2017 Mar 16;129(11):1469-1479
pubmed: 28049639
N Engl J Med. 2011 Aug 25;365(8):725-33
pubmed: 21830940
Cancer Discov. 2018 Oct;8(10):1300-1315
pubmed: 30093506
Nat Commun. 2016 May 20;7:11589
pubmed: 27199251
N Engl J Med. 2018 Mar 22;378(12):1107-1120
pubmed: 29562156
N Engl J Med. 1995 Oct 19;333(16):1052-7
pubmed: 7675049
J Clin Oncol. 2011 Jun 1;29(16):2223-9
pubmed: 21483000
J Clin Oncol. 2017 Sep 10;35(26):3010-3020
pubmed: 28715249
J Clin Oncol. 2008 May 10;26(14):2252-7
pubmed: 18467716
Blood. 2019 Sep 12;134(11):851-859
pubmed: 31340982
J Clin Oncol. 2010 Apr 1;28(10):1749-55
pubmed: 20194866
Blood. 2016 Jul 14;128(2):195-203
pubmed: 27247136
Blood. 1977 Dec;50(6):1049-59
pubmed: 336116
Leukemia. 2007 Sep;21(9):1984-91
pubmed: 17611561
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7
pubmed: 12218188
Blood. 2016 Jun 23;127(25):3215-24
pubmed: 27069256
N Engl J Med. 2000 Dec 28;343(26):1910-6
pubmed: 11136261
Cell. 1998 Mar 20;92(6):725-34
pubmed: 9529249
Blood. 2006 Aug 1;108(3):993-1000
pubmed: 16543464
Blood. 2018 Apr 26;131(17):1910-1919
pubmed: 29437592
Cancer Res. 1995 Nov 15;55(22):5187-90
pubmed: 7585571
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14973-7
pubmed: 10611322
Br J Haematol. 2010 Jul;150(2):237-9
pubmed: 20507307
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):883-7
pubmed: 15279773
Blood. 2018 Jun 21;131(25):2745-2760
pubmed: 29540348
Blood. 1993 Sep 15;82(6):1820-8
pubmed: 8104532
Lancet Oncol. 2019 Jan;20(1):43-56
pubmed: 30522969
Blood Cancer J. 2016 Jun 10;6:e434
pubmed: 27284738
Clin Cancer Res. 2008 Nov 1;14(21):6907-15
pubmed: 18980985
Cell. 1992 Jun 26;69(7):1237-45
pubmed: 1535557
Blood. 2018 Dec 6;132(23):2446-2455
pubmed: 30287523
Haematologica. 2019 Sep;104(9):e434-e437
pubmed: 31004028
J Clin Oncol. 2007 Mar 1;25(7):799-804
pubmed: 17283363
N Engl J Med. 2013 Jul 4;369(1):32-42
pubmed: 23782158
FEBS Lett. 1997 Dec 22;420(1):25-7
pubmed: 9450543
Blood. 2002 May 15;99(10):3554-61
pubmed: 11986207
J Exp Med. 2002 Sep 16;196(6):753-63
pubmed: 12235209
Cancer. 2011 Oct 15;117(20):4679-88
pubmed: 21455998
Blood. 2011 Aug 25;118(8):2062-8
pubmed: 21750315
Lancet Oncol. 2018 Jan;19(1):65-75
pubmed: 29246803
Oncotarget. 2010 Jul;1(3):168-74
pubmed: 21301048
J Clin Oncol. 1991 Jan;9(1):175-88
pubmed: 1702143
Science. 2000 May 12;288(5468):1053-8
pubmed: 10807576
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292-7
pubmed: 9653180
Mol Cell Biol. 2002 Dec;22(24):8580-91
pubmed: 12446777
Blood. 1994 Nov 1;84(9):3158-65
pubmed: 7949188
Lancet Oncol. 2018 Apr;19(4):486-496
pubmed: 29475723
Nat Biotechnol. 2018 May 9;36(5):375-377
pubmed: 29734306
Semin Oncol. 2000 Dec;27(6 Suppl 12):17-24
pubmed: 11225995
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):null
pubmed: 23378584
J Natl Cancer Inst. 1999 May 19;91(10):861-8
pubmed: 10340906
Leuk Lymphoma. 2002 Sep;43(9):1755-62
pubmed: 12685828
Lancet Oncol. 2017 Mar;18(3):297-311
pubmed: 28139405
Crit Rev Clin Lab Sci. 2019 Aug;56(5):321-332
pubmed: 30935269
Blood. 2008 Jan 15;111(2):846-55
pubmed: 17928528
Lancet Oncol. 2016 Oct;17(10):1409-1418
pubmed: 27637985
Nature. 1992 Jul 2;358(6381):15-6
pubmed: 1614522
Oncotarget. 2017 Jan 24;8(4):6102-6113
pubmed: 28008149
Clin Cancer Res. 2008 Jan 1;14(1):309-17
pubmed: 18172283
Blood Adv. 2019 May 14;3(9):1553-1562
pubmed: 31088809
Blood. 2005 Jun 15;105(12):4820-7
pubmed: 15728130
Haematologica. 2019 Apr;104(4):797-804
pubmed: 30467205
J Clin Oncol. 2019 Jun 1;37(16):1391-1402
pubmed: 30995176
Lancet Haematol. 2019 Feb;6(2):e67-e78
pubmed: 30642819
Blood. 2011 Jan 13;117(2):591-4
pubmed: 20959606
Cancer Discov. 2019 Mar;9(3):342-353
pubmed: 30514704
N Engl J Med. 2016 Jan 28;374(4):323-32
pubmed: 26641137
Hum Mutat. 2016 Sep;37(9):865-76
pubmed: 27328919
Semin Hematol. 2010 Apr;47(2):115-23
pubmed: 20350658
J Blood Med. 2019 Feb 27;10:71-84
pubmed: 30881167
Cell. 2004 Dec 17;119(6):847-60
pubmed: 15607980
J Clin Oncol. 2009 Aug 20;27(24):3994-4001
pubmed: 19597025
Nature. 1997 May 15;387(6630):299-303
pubmed: 9153396
Br J Haematol. 2018 Dec;183(5):727-735
pubmed: 30460980
Cell. 1997 Oct 31;91(3):325-34
pubmed: 9363941
Cancer Res. 1994 Jun 15;54(12):3131-5
pubmed: 8205530
Blood. 2004 Sep 15;104(6):1793-800
pubmed: 15172969
J Clin Oncol. 2010 Oct 10;28(29):4473-9
pubmed: 20697090
Clin Cancer Res. 2009 Feb 1;15(3):995-1004
pubmed: 19188171
Future Oncol. 2015;11(13):1895-903
pubmed: 26161926
N Engl J Med. 2014 Mar 13;370(11):997-1007
pubmed: 24450857
J Biol Chem. 2002 Jun 14;277(24):21843-50
pubmed: 11923280
N Engl J Med. 2014 Mar 20;370(12):1101-10
pubmed: 24401022
Mol Cell. 2001 Mar;7(3):683-94
pubmed: 11463392
Cell. 2004 Dec 17;119(6):861-72
pubmed: 15607981
Antisense Res Dev. 1994 Summer;4(2):71-9
pubmed: 7950302
Blood. 1998 Apr 15;91(8):2977-84
pubmed: 9531609
Lancet. 2007 Jul 21;370(9583):230-239
pubmed: 17658394
Cell Growth Differ. 2001 Apr;12(4):175-86
pubmed: 11331246
J Clin Oncol. 2008 Oct 20;26(30):4912-20
pubmed: 18794548
Science. 2002 Aug 9;297(5583):1031-4
pubmed: 12130661
Clin Cancer Res. 2015 Apr 1;21(7):1537-42
pubmed: 25670221
Expert Opin Biol Ther. 2001 Nov;1(6):1059-65
pubmed: 11728236
Cell Death Differ. 2019 Jan;26(2):199-212
pubmed: 30538286
Cancer. 2019 Feb 15;125(4):559-574
pubmed: 30508305
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15608-12
pubmed: 9861017
N Engl J Med. 2019 Jun 6;380(23):2225-2236
pubmed: 31166681
Blood. 1998 May 1;91(9):3379-89
pubmed: 9558396
Lancet Oncol. 2016 Jul;17(7):928-942
pubmed: 27216274
Blood. 2012 Apr 19;119(16):3668-83
pubmed: 22275381
Blood. 2011 Oct 20;118(16):4313-20
pubmed: 21816833
Cell. 1995 Jan 27;80(2):293-9
pubmed: 7834749
Haematologica. 2017 Oct;102(10):1629-1639
pubmed: 28775119
J Biol Chem. 2000 Mar 10;275(10):7337-42
pubmed: 10702305
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
J Clin Oncol. 2019 Feb 1;37(4):269-277
pubmed: 30523712
Blood. 2015 Apr 30;125(18):2779-85
pubmed: 25769620
Oncogene. 1994 Jun;9(6):1799-805
pubmed: 8183579
Blood. 2008 Oct 15;112(8):3322-9
pubmed: 18689542
Curr Biol. 1994 Jan 1;4(1):1-7
pubmed: 7922305
N Engl J Med. 2014 Jun 12;370(24):2286-94
pubmed: 24869598
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
pubmed: 17237035
Blood. 2013 Apr 18;121(16):3284-8
pubmed: 23435461

Auteurs

Marisa J L Aitken (MJL)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hun J Lee (HJ)

Department of Lymphoma and Multiple Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sean M Post (SM)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Houston, TX 77030-4000, USA.

Classifications MeSH